Snow Rothschild Acquisition
ISNRU · NASDAQ
About ISNRU
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Jun 9, 2026
- Sector
- N/A
- Industry
- N/A
ISNRU key statistics
- Market cap
- 276.85M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 844
- Volume
- 12
- Open price
- $9.91
- High today
- $9.91
- Low today
- $9.91
- 52 Week high
- $10.28
- 52 Week low
- $9.49
Snow Rothschild Acquisition (ISNRU) at a glance
Snow Rothschild Acquisition (ISNRU) last traded at $9.91, with a market cap of 276.85M and a price-to-earnings ratio of 0.00.
Volume so far is 12 shares, below the average of 844 shares a day.
Over the past year Snow Rothschild Acquisition has ranged from $9.49 to $10.28, and now sits 53% of the way up that range.
Most active stocks
Highest trading volume today
- GTVHGolden Triangle Ventures$0.0001−50.00%
- BURUNuburu$0.3717+115.98%
- RDARRaadr$0.0002+0.00%
- WFFWF Holding$0.06+13.21%
- INLFINLIF$0.265+47.22%
- EARIEntertainment Arts Research$0.0002+0.00%
- ADTADT$9.87+33.20%
- AITXArtificial Intelligence Technology Solutions$0.0008+77.78%
- GOOGLAlphabet$283.82−12.64%
- NVDGraniteShares ETF Trust$4.09+2.00%
- INTCIntel$92.07−3.62%
- TIPSTianrong Internet Products & Services$0.0015+7.14%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.98+0.10%
- LYCALycia Therapeutics$27.73+10.70%
- DAVIDAVION HEALTHCARE$2.69−18.24%
- TCXBTCGX Acquisition Corp. II$10.21−0.61%
- CTYCITY THERAPEUTICS$22.14+2.26%
- IAMIambic Therapeutics$14.28−3.38%
- AMROAmaero$5.78−1.37%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.21−0.20%
- TRXBTRex Bio$13.52−6.31%
- RTSNRetension Pharmaceuticals$11.83−9.63%
- PAXGUPine Tree Acquisition$10.02−0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.